Carbidopa-Levadopa Improves Speech Apraxia
After Open Traumatic Brain Injury
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Case Description

Medical Interventions

• A 24-year-old male with open traumatic brain
injury (TBI) due to gunshot wound (GSW).

• Carbidopa-Levadopa 25-100mg twice daily
started on day 40.

• Initial evaluation revealed a GCS of 3 with GSW to
left arm, left abdomen, left flank, and left skull.

• On day 46 of rehabilitation he was able to
consistently answer yes-no questions with ataxic
head nods and attempted spontaneous
communication but was unable to do so due to
apraxia of speech.

• Initial work up with CT-Head showed extensive
subarachnoid hemorrhage and cerebral edema
with residual bullet fragments in the posterior
fossa.
• Thirty days later he was transferred to our
rehabilitation hospital.

Physical Examination
• Significant bilateral limb ataxia
• Mutism without facial weakness.
• Speech-language pathology (SLP) evaluation
noted effortful groping, frustration, mild facial
weakness, and severe impairment most
consistent with speech apraxia.
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• His speech did not improve further and on day 54
his carbidopa-levadopa was increased to 25100mg three times daily. After two doses he was
able to make unintelligible voice.
• He again plateaued and on day 64, carbidopalevadopa was titrated to 50-200mg three times
daily and on the same day he was able to
phonate the entire alphabet with max cueing.
• Over the next few weeks he had improved
intelligibility, consistently produced simple 2-3
word sentences, answered questions of
preference with a single word, and correctly
identified 50% of one-word images on
articulation cards, 75% with phonemic or phrase
closure cues, and 100% with verbal model.

Discussion
• Carbidopa-Levadopa has been reported
previously in a case to improve speech apraxia
1
after hypoxic ischemic encephalopathy
• This patient demonstrated a clear step-like
response to Carbidopa-Levadopa with near
immediate improvent after each dose increase.
• Carbidopa-Levadeopa has previously been shown
to lead to a dose-dependent improvement in
2
apraxia of lid opening

Conclusion
• This marks the first reported case of dosedependent improvement in apraxia of speech
with the use of Carbidopa-Levadopa.
• Carbidopa-Levadopa should be further
investigated for use in apraxic conditions.

Disclosures
None

References
1. Ingraham B and Ripley DL. Carbidopa-Levodopa
Improves Speech Apraxia after Hypoxic-Ischemic
Brain Injury: A Case Report. PMR. 2016. 8(9S):S232
2. Lee KC, Finley R, and Miller B. Apraxia of lid
opening: dose-dependent response to carbidopalevodopa. Pharmacotherpy. 2004. 24(3):401-3

